(Press-News.org) MANHASSET, NY -- Molecular Medicine, a peer-reviewed biomedical journal published by the Feinstein Institute Press, published the results of a new study reporting clinically significant pain reduction in type 2 diabetic patients. In an exploratory study conducted by Araim Pharmaceuticals, a biotech company developing novel treatments for chronic diseases, investigators also observed improvements in metabolic control in patients administered ARA 290. ARA 290 is a peptide engineered to activate the innate repair receptor, a receptor discovered by Araim scientists, which is only expressed following tissue damage or stress.
In the initial study, patients were administered ARA 290, a novel, first-in-class drug, daily for 28 days, with the purpose of evaluating its efficacy in treating neuropathic pain, a common condition among diabetics. When ARA 290 is administered, the repair receptor is activated and subsequently turns off inflammation and turns on the body's natural repair system. The short half-life of ARA 290, coupled with the restricted expression of the innate repair receptor, functions as a dual safety system to avoid potential side effects.
"The results from this study indicate a major breakthrough in the treatment of diabetes," said Kevin J. Tracey, MD, president of the Feinstein Institute for Medical Research and Editor of Molecular Medicine. "Over the years, Molecular Medicine has prided itself on publishing groundbreaking papers with implications on the broader medical community, and we're proud to have a potential disease-modifying solution to diabetes featured in the current issue."
The clinically significant results and excellent safety profile support Araim's development strategy of two future studies in 2015. First, metabolic improvement will be studied in type 2 diabetics with moderate kidney damage. Second, neuropathic pain reduction will be assessed in a multi-center proof of concept trial in type 1 diabetics. Both phase 2 clinical trials will be conducted in the United Kingdom, and patients will be dosed daily for six months to allow time for adequate tissue repair.
"We're excited to be on the cusp of the first diabetic disease modifier that demonstrates the potential to repair the complications of diabetes systemically," said Anthony Cerami, PhD, CEO of Araim Pharmaceuticals." Dr. Cerami developed the HbA1c diagnostic test, the current gold standard for diagnosing diabetes.
INFORMATION:
The research was supported in part by a grant from the Netherlands Institute for Regenerative Medicine. Read the full report in http://www.molmed.org.
About Araim Pharmaceuticals, Inc.
Araim Pharmaceuticals, Inc. is a privately held biotech company founded in 2006 engaged in developing novel treatments for devastating injuries and chronic diseases underserved by current therapies. Their lead compound, ARA 290, is a novel 11 amino acid peptide engineered to specifically activate the body's natural repair system via the innate repair receptor that is present only following injury. ARA 290 activates anti-inflammatory, tissue protective, and reparative signaling pathways. The short half-life of ARA 290 coupled with the restricted expression of the innate repair receptor functions as a dual safety system to avoid potential side effects. Clinical trials evaluating ARA 290 for treatment of neuropathic symptoms associated with diabetes and the orphan disease sarcoidosis are currently ongoing in the US and Europe. ARA 290 has received orphan drug designation in the US and in Europe, as well as Fast Track designation in the US for treatment of small fiber neuropathy in sarcoidosis. http://www.araimpharma.com
About Molecular Medicine
Molecular Medicine is an open access, international, peer-reviewed biomedical journal published by the Feinstein Institute Press. Molecular Medicine strives to understand normal body functioning and disease pathogenesis at the molecular level, which may allow researchers and physician-scientists to use that knowledge in the design of specific molecular tools for disease diagnosis, treatment, prognosis, and prevention. To learn more, visit http://www.molmed.org.
About The Feinstein Institute for Medical Research
Headquartered in Manhasset, NY, The Feinstein Institute for Medical Research is home to international scientific leaders in many areas including Parkinson's disease, Alzheimer's disease, psychiatric disorders, rheumatoid arthritis, lupus, sepsis, human genetics, pulmonary hypertension, leukemia, neuroimmunology, and medicinal chemistry. The Feinstein Institute, part of the North Shore-LIJ Health System, ranks in the top 6th percentile of all National Institutes of Health grants awarded to research centers. For more information, visit http://www.FeinsteinInstitute.org.
Scientists at Johannes Gutenberg University Mainz (JGU) in Germany have discovered a new signal pathway in the brain that plays an important role in learning and the processing of sensory input. It was already known that distinct glial cells receive information from neurons. However, it was unknown that these same glial cells also transmit information to neurons. The glia release a specific protein fragment that influences neuronal cross-talk, most likely by binding to the synaptic contacts that neurons use for communication. Disruption of this information flow from the ...
New research led by the University of Exeter has found that people who have a stronger sense of place at the global than the national level are more likely to accept that climate change is caused by human activities. This is the first time that acceptance of human causes of climate change has been shown to be linked to people's sense of place at the global level. The findings have significant implications both for climate change communications and for our understanding of place and identities.
The study 'My country or my planet? Exploring the influence of multiple place ...
BLOOMINGTON, Ind. -- Scientists at Indiana University and colleagues at Stanford and the University of Texas have demonstrated a technique for "editing" the genome in sperm-producing adult stem cells, a result with powerful potential for basic research and for gene therapy.
The researchers completed a "proof of concept" experiment in which they created a break in the DNA strands of a mutant gene in mouse cells, then repaired the DNA through a process called homologous recombination, replacing flawed segments with correct ones.
The study involved spermatogonial stem ...
Patients with Parkinson's, medics and carers have identified the top ten priorities for research into the management of the condition in a study by the University of East Anglia and Parkinson's UK.
Commissioned by Parkinson's UK, people with direct and indirect personal experience of the condition worked together to identify crucial gaps in the existing evidence to address everyday practicalities in the management of the complexities of Parkinson's. Patients stated that the overarching research aspiration was an effective cure for Parkinson's but whilst waiting for this ...
DALLAS - Dec. 15, 2014 - UT Southwestern Medical Center neurology researchers have identified an important cell signaling mechanism that plays an important role in brain cancer and may provide a new therapeutic target.
Researchers found that this mechanism -- a type of signaling termed constitutive or non-canonical epidermal growth factor receptor (EGFR) signaling -- is highly active in glioblastomas, the most common type of adult brain cancer and a devastating disease with a poor prognosis.
When activated in cancer cells, it protects the tumor cells, making them more ...
In the same way as we now connect computers in networks through optical signals, it could also be possible to connect future quantum computers in a 'quantum internet'. The optical signals would then consist of individual light particles or photons. One prerequisite for a working quantum internet is control of the shape of these photons. Researchers at Eindhoven University of Technology (TU/e) and the FOM foundation have now succeeded for the first time in getting this control within the required short time. These findings are published today in Nature Communications.
Quantum ...
For decades, the mantra of electronics has been smaller, faster, cheaper.
Today, Stanford engineers add a fourth word - taller.
At a conference in San Francisco, a Stanford team will reveal how to build high-rise chips that could leapfrog the performance of the single-story logic and memory chips on today's circuit cards.
Those circuit cards are like busy cities in which logic chips compute and memory chips store data. But when the computer gets busy, the wires connecting logic and memory can get jammed.
The Stanford approach would end these jams by building layers ...
PEOPLE who have problems with numbers may be more likely to feel negative about bowel cancer screening, including fearing an abnormal result, while some think the test is disgusting or embarrassing, according to a Cancer Research UK supported study* published today (Monday) in the Journal of Health Psychology.
The researchers** sent information about bowel cancer screening to patients aged from 45 to 59 along with a questionnaire which assessed their numerical skills and attitudes to the screening test, which looks for blood in stool samples.
Almost 965 people - registered ...
E-cigarette use among teenagers is growing in the U.S., and Hawaii teens take up e-cigarette use at higher rates than their mainland counterparts, a new study by University of Hawaii Cancer Center researchers has found.
The findings come as e-cigarettes grow in popularity and the Food and Drug Administration is considering how to regulate their sale. Some public health officials are concerned that e-cigarettes may be recruiting a new generation of young cigarette smokers who otherwise might not take up smoking at all, and the study's results bolster this position.
Data ...
While serious infections can be transmitted from donated organs, the risk of passing Ebola virus disease from an organ donor to a recipient is extremely small. In a new editorial published in the American Journal of Transplantation, experts explain how simple assessments of donors can help ensure that the organ supply is safe, while having little impact on the donor pool.
Despite screening all organ donors for infection, on rare occasions an organ donor will transmit an unexpected infection to a recipient. Because cases of Ebola virus disease have occurred in the United ...
